论文部分内容阅读
生物技术公司一直致力于实现个人基因组测序的快速化、低成本化,同时提高利润率。但截止到2008年年末,只有不到10个个体的基因组序列得到测定,且耗
Biotech companies have been working to make personal genome sequencing faster and lower cost while increasing profit margins. However, as of the end of 2008, only less than 10 individuals had their genomic sequences determined and consumed